Folgen
Thomas Nefau
Thomas Nefau
PhD & PharmD at the French Monitoring Centre on Drugs and Drug Addictions (OFDT)
Bestätigte E-Mail-Adresse bei ofdt.fr
Titel
Zitiert von
Zitiert von
Jahr
Spatial differences and temporal changes in illicit drug use in E urope quantified by wastewater analysis
C Ort, ALN van Nuijs, JD Berset, L Bijlsma, S Castiglioni, A Covaci, ...
Addiction 109 (8), 1338-1352, 2014
4232014
Spatio‐temporal assessment of illicit drug use at large scale: evidence from 7 years of international wastewater monitoring
I González‐Mariño, JA Baz‐Lomba, NA Alygizakis, MJ Andrés‐Costa, ...
Addiction 115 (1), 109-120, 2020
1902020
Estimation of illicit drugs consumption by wastewater analysis in Paris area (France)
S Karolak, T Nefau, E Bailly, A Solgadi, Y Levi
Forensic science international 200 (1-3), 153-160, 2010
1622010
Presence of illicit drugs and metabolites in influents and effluents of 25 sewage water treatment plants and map of drug consumption in France
T Nefau, S Karolak, L Castillo, V Boireau, Y Levi
Science of the Total Environment 461, 712-722, 2013
1462013
Online test purchased new psychoactive substances in 5 different European countries: A snapshot study of chemical composition and price
TM Brunt, AM Atkinson, T Nefau, M Martinez, E Lahaie, A Malzcewski, ...
International Journal of Drug Policy 44, 105-114, 2017
542017
The removal of illicit drugs and morphine in two waste water treatment plants (WWTPs) under tropical conditions
DA Devault, T Néfau, Y Levi, S Karolak
Environmental Science and Pollution Research 24, 25645-25655, 2017
392017
Drug analysis of residual content of used syringes: a new approach for improving knowledge of injected drugs and drug user practices
T Néfau, E Charpentier, N Elyasmino, C Duplessy-Garson, Y Levi, ...
International Journal of Drug Policy 26 (4), 412-419, 2015
382015
Hepatitis C transmission in injection drug users: could swabs be the main culprit?
V Thibault, JL Bara, T Nefau, C Duplessy-Garson
The Journal of infectious diseases 204 (12), 1839-1842, 2011
322011
CHEMSEX, NPS & risk reduction management: Preliminary results of a pilot study
M Marillier, A Batisse, C Richeval, V Labrouve, M Martinez, D Allorge, ...
Toxicologie Analytique et Clinique 29 (1), 47-56, 2017
282017
Substances detected in used syringes of injecting drug users across 7 cities in Europe in 2017 and 2018: The European Syringe Collection and Analysis Project Enterprise (ESCAPE)
TM Brunt, E Lefrançois, T Gunnar, A Arponen, T Seyler, AE Goudriaan, ...
International Journal of Drug Policy 95, 103130, 2021
202021
Substances psychoactives en France: tendances récentes (2014-2015)
A Cadet-Taïrou, M Gandilhon, M Martinez, T Néfau
Tendances 105, 2015
172015
Substances psychoactives, usagers et marchés: les tendances récentes (2016-2017)
A Cadet-Taïrou, M Gandilhon, M Martinez, M Milhet, T Néfau
Tendances 121, 1-8, 2017
152017
Substances psychoactives, usagers et marchés: les tendances récentes (2015-2016)
A Cadet-Taïrou, M Gandilhon, M Martinez, T Néfau, M Milhet
Tendances 115, 8, 2016
142016
Substances illicites ou détournées: les tendances récentes (2013-2014)
A Cadet-Taïrou, M Gandilhon, M Martinez, T Néfau
Tendances 96 (6), 2014
142014
Nouveaux produits de synthèse. Dix ans de recul sur la situation française. Tendances n° 127
M Martinez, T Néfau, A Cadet-Taïrou
132018
Theory versus practice, bacteriological efficiency versus personal habits: a bacteriological and user acceptability evaluation of filtering tools for people who inject drugs
M Jauffret‐Roustide, A Chollet, A Santos, T Benoit, S Péchiné, ...
Drug and Alcohol Review 37 (1), 106-115, 2018
122018
Nouveaux produits de synthèse identifiés en France depuis 2000
T Néfau, M Martinez
Note d’information SINTES, 2014
112014
HaRePo (harm reduction by post): an innovative and effective harm reduction programme for people who use drugs using email, telephone, and post service
M Torres-Leguizamon, EG Reynaud, T Néfau, C Duplessy
Harm reduction journal 17, 1-13, 2020
102020
Chemsex, slam
M Milhet, T Néfau, L Bordeaux, P Marseille
Renouvellement des usages de drogues en contextes sexuels parmi les HSH …, 2017
102017
The comeback of Ecstasy: New designs and increased MDMA content
C Richeval, L Humbert, T Nefau, M Martinez, D Allorge, JM Gaulier
Toxicologie Analytique et Clinique 29 (1), 144-145, 2017
82017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20